ARCHIVES

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

This article is from The Cancer Letter archive.

Vol. 09 No. 39 | October 14, 1983

Download PDF Visit The Full Archive

Related Articles

Richard Pazdur’s Comments to ODAC

July 22, 2011

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

Breast Cancer Risk Prediction Improved In Atypia Cases

July 27, 2007

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

Barnett Kramer Next Director Of NCI Division of Cancer Prevention

July 29, 2011